Uroprotective and Hepatoprotective Potential of Anagallis arvensis against the Experimental Animal Model

Table 2

Effect of A. arvensis on vesical vascular permeability.

Groups	Optical density
Control	0.004 ± 3.33
Diseased control	0.069 ± 0.001
Standard drug-treated	0.005 ± 0.001
MEOAA (250 mg/kg)-treated	0.014 ± 0.001
MEOAA (500 mg/kg)-treated	0.009 ± 0.001

Determination of the vesical vascular permeability from control, diseased control, standard drug (Mesna 40 mg/kg), and methanol extract of A. arvensis (MEOAA) (250 mg/kg and 500 mg/kg) -treated groups of rats ( compared to the control group, compared to diseased control group; n = 4).